Minerva Neurosciences, Inc. (NERV)
NASDAQ: NERV · Real-Time Price · USD
2.250
+0.070 (3.21%)
At close: Sep 15, 2025, 4:00 PM EDT
2.210
-0.040 (-1.78%)
After-hours: Sep 15, 2025, 5:26 PM EDT
Minerva Neurosciences Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Minerva Neurosciences stock has a target of 5.00, which predicts a 122.22% increase from the current stock price of 2.25.
Price Target: $5.00 (+122.22%)
Analyst Consensus: Hold
* Price targets were last updated on Feb 26, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for Minerva Neurosciences is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $5 | Hold | Reiterates | $5 | +122.22% | Feb 26, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $5 | Hold | Reiterates | $5 | +122.22% | Nov 6, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $7 → $5 | Hold | Maintains | $7 → $5 | +122.22% | Aug 7, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $11 → $7 | Hold | Maintains | $11 → $7 | +211.11% | May 2, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $11 | Hold | Reiterates | $11 | +388.89% | Feb 27, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.73
from 0.19
EPS Next Year
-1.92
from -2.73
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | n/a | |||
| Avg | n/a | n/a | |||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -2.81 | -1.97 | |||
| Avg | -2.73 | -1.92 | |||
| Low | -2.63 | -1.84 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.